Escitalopram

Product NDC: 63629-4699
11-digit product format: 636294699
Labeler code: 63629
Product ID: 63629-4699_edd9fe1d-ef9c-4eac-8d4b-4903f3447a38
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Escitalopram
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: Bryant Ranch Prepack
Application: ANDA076765
Marketing category: ANDA
Marketing start: 2012-03-14
Marketing end: 0000-00-00
Substance: ESCITALOPRAM OXALATE
Active strength: 20 mg/1
Pharmacologic classes: Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2019-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 8 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	63629-4699		D	Discontinued by firm	2026-08-17
excluded package	package	63629-4699	63629-4699-1	D	Discontinued by firm	2026-08-17
excluded package	package	63629-4699	63629-4699-2	D	Discontinued by firm	2026-08-17
excluded package	package	63629-4699	63629-4699-3	D	Discontinued by firm	2026-08-17
excluded package	package	63629-4699	63629-4699-4	D	Discontinued by firm	2026-08-17
excluded package	package	63629-4699	63629-4699-5	D	Discontinued by firm	2026-08-17
excluded package	package	63629-4699	63629-4699-6	D	Discontinued by firm	2026-08-17
excluded package	package	63629-4699	63629-4699-7	D	Discontinued by firm	2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 120 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63629-4699-5	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63629-4699-7	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63629-4699-1	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63629-4699-6	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63629-4699-3	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63629-4699-2	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63629-4699-4	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63629-4699-5	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63629-4699-7	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63629-4699-1	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63629-4699-6	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63629-4699-3	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63629-4699-2	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63629-4699-4	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63629-4699-5	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63629-4699-7	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63629-4699-1	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63629-4699-6	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63629-4699-3	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63629-4699-2	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63629-4699-4	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	63629-4699-5	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	63629-4699-7	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	63629-4699-1	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	63629-4699-6	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	63629-4699-3	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	63629-4699-2	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	63629-4699-4	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	63629-4699-5	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	63629-4699-7	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	63629-4699-1	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	63629-4699-6	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	63629-4699-3	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	63629-4699-2	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	63629-4699-4	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	63629-4699-5	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	63629-4699-7	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	63629-4699-1	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	63629-4699-6	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	63629-4699-3	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	63629-4699-2	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	63629-4699-4	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	63629-4699-5	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	63629-4699-7	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	63629-4699-1	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	63629-4699-6	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	63629-4699-3	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	63629-4699-2	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	63629-4699-4	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	63629-4699-5	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	63629-4699-7	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	63629-4699-1	`ed331223b511…`	`672a5bd82f5f…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	Approval date
A076765-001	ESCITALOPRAM OXALATE	ESCITALOPRAM OXALATE	EQ 5MG BASE	TABLET / ORAL	2012-03-14
A076765-002	ESCITALOPRAM OXALATE	ESCITALOPRAM OXALATE	EQ 10MG BASE	TABLET / ORAL	2012-03-14
A076765-003	ESCITALOPRAM OXALATE	ESCITALOPRAM OXALATE	EQ 20MG BASE	TABLET / ORAL	2012-03-14

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 126 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A076765-001	ESCITALOPRAM OXALATE	EQ 5MG BASE	TABLET / ORAL	2012-03-14	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A076765-002	ESCITALOPRAM OXALATE	EQ 10MG BASE	TABLET / ORAL	2012-03-14	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A076765-003	ESCITALOPRAM OXALATE	EQ 20MG BASE	TABLET / ORAL	2012-03-14	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A076765-001	ESCITALOPRAM OXALATE	EQ 5MG BASE	TABLET / ORAL	2012-03-14	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076765-002	ESCITALOPRAM OXALATE	EQ 10MG BASE	TABLET / ORAL	2012-03-14	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076765-003	ESCITALOPRAM OXALATE	EQ 20MG BASE	TABLET / ORAL	2012-03-14	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076765-001	ESCITALOPRAM OXALATE	EQ 5MG BASE	TABLET / ORAL	2012-03-14	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076765-002	ESCITALOPRAM OXALATE	EQ 10MG BASE	TABLET / ORAL	2012-03-14	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076765-003	ESCITALOPRAM OXALATE	EQ 20MG BASE	TABLET / ORAL	2012-03-14	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A076765-001	ESCITALOPRAM OXALATE	EQ 5MG BASE	TABLET / ORAL	2012-03-14	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A076765-002	ESCITALOPRAM OXALATE	EQ 10MG BASE	TABLET / ORAL	2012-03-14	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A076765-003	ESCITALOPRAM OXALATE	EQ 20MG BASE	TABLET / ORAL	2012-03-14	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076765-001	ESCITALOPRAM OXALATE	EQ 5MG BASE	TABLET / ORAL	2012-03-14	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076765-002	ESCITALOPRAM OXALATE	EQ 10MG BASE	TABLET / ORAL	2012-03-14	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076765-003	ESCITALOPRAM OXALATE	EQ 20MG BASE	TABLET / ORAL	2012-03-14	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076765-001	ESCITALOPRAM OXALATE	EQ 5MG BASE	TABLET / ORAL	2012-03-14	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076765-002	ESCITALOPRAM OXALATE	EQ 10MG BASE	TABLET / ORAL	2012-03-14	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076765-003	ESCITALOPRAM OXALATE	EQ 20MG BASE	TABLET / ORAL	2012-03-14	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076765-001	ESCITALOPRAM OXALATE	EQ 5MG BASE	TABLET / ORAL	2012-03-14	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076765-002	ESCITALOPRAM OXALATE	EQ 10MG BASE	TABLET / ORAL	2012-03-14	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076765-003	ESCITALOPRAM OXALATE	EQ 20MG BASE	TABLET / ORAL	2012-03-14	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076765-001	ESCITALOPRAM OXALATE	EQ 5MG BASE	TABLET / ORAL	2012-03-14	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076765-002	ESCITALOPRAM OXALATE	EQ 10MG BASE	TABLET / ORAL	2012-03-14	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076765-003	ESCITALOPRAM OXALATE	EQ 20MG BASE	TABLET / ORAL	2012-03-14	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076765-001	ESCITALOPRAM OXALATE	EQ 5MG BASE	TABLET / ORAL	2012-03-14	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076765-002	ESCITALOPRAM OXALATE	EQ 10MG BASE	TABLET / ORAL	2012-03-14	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076765-003	ESCITALOPRAM OXALATE	EQ 20MG BASE	TABLET / ORAL	2012-03-14	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076765-001	ESCITALOPRAM OXALATE	EQ 5MG BASE	TABLET / ORAL	2012-03-14	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076765-002	ESCITALOPRAM OXALATE	EQ 10MG BASE	TABLET / ORAL	2012-03-14	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076765-003	ESCITALOPRAM OXALATE	EQ 20MG BASE	TABLET / ORAL	2012-03-14	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A076765-001	ESCITALOPRAM OXALATE	EQ 5MG BASE	TABLET / ORAL	2012-03-14	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A076765-002	ESCITALOPRAM OXALATE	EQ 10MG BASE	TABLET / ORAL	2012-03-14	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A076765-003	ESCITALOPRAM OXALATE	EQ 20MG BASE	TABLET / ORAL	2012-03-14	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076765-001	ESCITALOPRAM OXALATE	EQ 5MG BASE	TABLET / ORAL	2012-03-14	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076765-002	ESCITALOPRAM OXALATE	EQ 10MG BASE	TABLET / ORAL	2012-03-14	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076765-003	ESCITALOPRAM OXALATE	EQ 20MG BASE	TABLET / ORAL	2012-03-14	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076765-001	ESCITALOPRAM OXALATE	EQ 5MG BASE	TABLET / ORAL	2012-03-14	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076765-002	ESCITALOPRAM OXALATE	EQ 10MG BASE	TABLET / ORAL	2012-03-14	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076765-003	ESCITALOPRAM OXALATE	EQ 20MG BASE	TABLET / ORAL	2012-03-14	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A076765-001	ESCITALOPRAM OXALATE	EQ 5MG BASE	TABLET / ORAL	2012-03-14	`1e350fbaab3a…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 51 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A076765-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A076765-002	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A076765-003	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A076765-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A076765-002	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A076765-003	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A076765-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A076765-002	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A076765-003	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A076765-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A076765-002	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A076765-003	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A076765-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A076765-002	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A076765-003	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A076765-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A076765-002	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A076765-003	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A076765-001	AB	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A076765-002	AB	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A076765-003	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A076765-001	AB	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	A076765-002	AB	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	A076765-003	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A076765-001	AB	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	A076765-002	AB	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	A076765-003	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A076765-001	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	A076765-002	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	A076765-003	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A076765-001	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A076765-002	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A076765-003	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A076765-001	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A076765-002	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A076765-003	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A076765-001	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A076765-002	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A076765-003	AB	1	`ea99ee380514…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A076765-001	AB	1	`3a93d1ddd44b…`

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
63629-4699-1	2022-02-16	These highlights do not include all the information needed to use ESCITALOPRAM TABLETS safely and effectively. See full prescribing information for ESCITALOPRAM TABLETS. ESCITALOPRAM tablets, for oral use Initial U.S. Approval: 2002
63629-4699-2	2022-02-16	These highlights do not include all the information needed to use ESCITALOPRAM TABLETS safely and effectively. See full prescribing information for ESCITALOPRAM TABLETS. ESCITALOPRAM tablets, for oral use Initial U.S. Approval: 2002
63629-4699-3	2022-02-16	These highlights do not include all the information needed to use ESCITALOPRAM TABLETS safely and effectively. See full prescribing information for ESCITALOPRAM TABLETS. ESCITALOPRAM tablets, for oral use Initial U.S. Approval: 2002
63629-4699-4	2022-02-16	These highlights do not include all the information needed to use ESCITALOPRAM TABLETS safely and effectively. See full prescribing information for ESCITALOPRAM TABLETS. ESCITALOPRAM tablets, for oral use Initial U.S. Approval: 2002
63629-4699-5	2022-02-16	These highlights do not include all the information needed to use ESCITALOPRAM TABLETS safely and effectively. See full prescribing information for ESCITALOPRAM TABLETS. ESCITALOPRAM tablets, for oral use Initial U.S. Approval: 2002
63629-4699-6	2022-02-16	These highlights do not include all the information needed to use ESCITALOPRAM TABLETS safely and effectively. See full prescribing information for ESCITALOPRAM TABLETS. ESCITALOPRAM tablets, for oral use Initial U.S. Approval: 2002
63629-4699-7	2022-02-16	These highlights do not include all the information needed to use ESCITALOPRAM TABLETS safely and effectively. See full prescribing information for ESCITALOPRAM TABLETS. ESCITALOPRAM tablets, for oral use Initial U.S. Approval: 2002
63629-4699-1	2020-01-31	These highlights do not include all the information needed to use ESCITALOPRAM TABLETS safely and effectively. See full prescribing information for ESCITALOPRAM TABLETS. ESCITALOPRAM tablets, for oral use Initial U.S. Approval: 2002
63629-4699-2	2020-01-31	These highlights do not include all the information needed to use ESCITALOPRAM TABLETS safely and effectively. See full prescribing information for ESCITALOPRAM TABLETS. ESCITALOPRAM tablets, for oral use Initial U.S. Approval: 2002
63629-4699-3	2020-01-31	These highlights do not include all the information needed to use ESCITALOPRAM TABLETS safely and effectively. See full prescribing information for ESCITALOPRAM TABLETS. ESCITALOPRAM tablets, for oral use Initial U.S. Approval: 2002
63629-4699-4	2020-01-31	These highlights do not include all the information needed to use ESCITALOPRAM TABLETS safely and effectively. See full prescribing information for ESCITALOPRAM TABLETS. ESCITALOPRAM tablets, for oral use Initial U.S. Approval: 2002
63629-4699-5	2020-01-31	These highlights do not include all the information needed to use ESCITALOPRAM TABLETS safely and effectively. See full prescribing information for ESCITALOPRAM TABLETS. ESCITALOPRAM tablets, for oral use Initial U.S. Approval: 2002
63629-4699-6	2020-01-31	These highlights do not include all the information needed to use ESCITALOPRAM TABLETS safely and effectively. See full prescribing information for ESCITALOPRAM TABLETS. ESCITALOPRAM tablets, for oral use Initial U.S. Approval: 2002
63629-4699-7	2020-01-31	These highlights do not include all the information needed to use ESCITALOPRAM TABLETS safely and effectively. See full prescribing information for ESCITALOPRAM TABLETS. ESCITALOPRAM tablets, for oral use Initial U.S. Approval: 2002

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
63629-4699-1	EA - Each	63629-4699	054cf657-92d9-4c04-b0d2-5d15006837c1	1	2013-02-13
63629-4699-2	EA - Each	63629-4699	07db4b56-01f9-4952-875d-6b8696fd0f35	1	2013-02-13
63629-4699-3	EA - Each	63629-4699	94a8cab5-613a-48de-b911-3f034e698c44	1	2013-02-13
63629-4699-4	EA - Each	63629-4699	5cbb007a-8f56-4bce-8ff9-983802a7c519	1	2016-12-07
63629-4699-5	EA - Each	63629-4699	8b0c6322-c525-4cf5-8857-51a4fdd2811f	1	2016-12-07
63629-4699-6	EA - Each	63629-4699	ece19405-256d-4516-b144-af88cb1044e1	1	2016-12-07
63629-4699-7	EA - Each	63629-4699	64ea5317-2ad8-4a67-9366-2be6c30dbd70	1	2016-12-07

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
ESCITALOPRAM OXALATE	ACTIVE INGREDIENT	5U85DBW7LO	ESCITALOPRAM TABLET, FILM COATED [BRYANT RANCH PREPACK]	1002
ESCITALOPRAM	ACTIVE MOIETY	4O4S742ANY	ESCITALOPRAM TABLET, FILM COATED [BRYANT RANCH PREPACK]	1002
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	ESCITALOPRAM TABLET, FILM COATED [BRYANT RANCH PREPACK]	1002
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	ESCITALOPRAM TABLET, FILM COATED [BRYANT RANCH PREPACK]	1002
HYPROMELLOSE 2910 (15 MPA.S)	INACTIVE INGREDIENT	36SFW2JZ0W	ESCITALOPRAM TABLET, FILM COATED [BRYANT RANCH PREPACK]	1002
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	ESCITALOPRAM TABLET, FILM COATED [BRYANT RANCH PREPACK]	1002
MANNITOL	INACTIVE INGREDIENT	3OWL53L36A	ESCITALOPRAM TABLET, FILM COATED [BRYANT RANCH PREPACK]	1002
POLYETHYLENE GLYCOL 6000	INACTIVE INGREDIENT	30IQX730WE	ESCITALOPRAM TABLET, FILM COATED [BRYANT RANCH PREPACK]	1002
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	ESCITALOPRAM TABLET, FILM COATED [BRYANT RANCH PREPACK]	1002
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	ESCITALOPRAM TABLET, FILM COATED [BRYANT RANCH PREPACK]	1002

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
5U85DBW7LO	ESCITALOPRAM OXALATE	219861-08-2	ESCITALOPRAM OXALATE
4O4S742ANY	ESCITALOPRAM	128196-01-0	Escitalopram